176 related articles for article (PubMed ID: 36672171)
21. Oncogenic BRAF, endoplasmic reticulum stress, and autophagy: Crosstalk and therapeutic targets in cutaneous melanoma.
Rather RA; Bhagat M; Singh SK
Mutat Res Rev Mutat Res; 2020; 785():108321. PubMed ID: 32800272
[TBL] [Abstract][Full Text] [Related]
22. Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma.
Cappabianca L; Farina AR; Di Marcotullio L; Infante P; De Simone D; Sebastiano M; Mackay AR
J Exp Clin Cancer Res; 2019 Dec; 38(1):482. PubMed ID: 31805994
[TBL] [Abstract][Full Text] [Related]
23. Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.
Duggan MC; Regan-Fendt K; Olaverria Salavaggione GN; Howard JH; Stiff AR; Sabella J; Latchana N; Markowitz J; Gru A; Tridandapani S; Eisfeld AK; de la Chapelle A; Carson WE
Melanoma Res; 2019 Oct; 29(5):491-500. PubMed ID: 31116161
[TBL] [Abstract][Full Text] [Related]
24. Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia.
Lebedev TD; Vagapova ER; Popenko VI; Leonova OG; Spirin PV; Prassolov VS
Front Oncol; 2019; 9():1046. PubMed ID: 31681584
[TBL] [Abstract][Full Text] [Related]
25. Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.
Eggert A; Ho R; Ikegaki N; Liu XG; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):623-7. PubMed ID: 11107132
[TBL] [Abstract][Full Text] [Related]
26. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
Bai Y; Kinne J; Donham B; Jiang F; Ding L; Hassler JR; Kaufman RJ
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
[TBL] [Abstract][Full Text] [Related]
27. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
28. Comparison of tyrosine kinase domain properties for the neurotrophin receptors TrkA and TrkB.
Artim SC; Kiyatkin A; Lemmon MA
Biochem J; 2020 Oct; 477(20):4053-4070. PubMed ID: 33043964
[TBL] [Abstract][Full Text] [Related]
29. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
30. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA.
Herrmann JL; Menter DG; Hamada J; Marchetti D; Nakajima M; Nicolson GL
Mol Biol Cell; 1993 Nov; 4(11):1205-16. PubMed ID: 8305739
[TBL] [Abstract][Full Text] [Related]
31. Tropomyosin-Related Kinase Receptor and Neurotrophin Expression in Cutaneous Melanoma Is Associated with a Poor Prognosis and Decreased Survival.
Antunes LCM; Cartell A; de Farias CB; Bakos RM; Roesler R; Schwartsmann G
Oncology; 2019; 97(1):26-37. PubMed ID: 31071716
[TBL] [Abstract][Full Text] [Related]
32. Novel mechanisms of resistance to vemurafenib in melanoma - V600E B-Raf reversion and switching VEGF-A splice isoform expression.
Beazley-Long N; Gaston K; Harper SJ; Orlando A; Bates DO
Am J Cancer Res; 2015; 5(1):433-41. PubMed ID: 25628951
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma.
McKee CS; Hill DS; Redfern CP; Armstrong JL; Lovat PE
Exp Dermatol; 2013 Nov; 22(11):767-9. PubMed ID: 24118207
[TBL] [Abstract][Full Text] [Related]
34. NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib.
Aubert L; Guilbert M; Corbet C; Génot E; Adriaenssens E; Chassat T; Bertucci F; Daubon T; Magné N; Le Bourhis X; Toillon RA
Oncotarget; 2015; 6(12):9807-19. PubMed ID: 25840418
[TBL] [Abstract][Full Text] [Related]
35. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
36. Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
Drilon A; Siena S; Ou SI; Patel M; Ahn MJ; Lee J; Bauer TM; Farago AF; Wheler JJ; Liu SV; Doebele R; Giannetta L; Cerea G; Marrapese G; Schirru M; Amatu A; Bencardino K; Palmeri L; Sartore-Bianchi A; Vanzulli A; Cresta S; Damian S; Duca M; Ardini E; Li G; Christiansen J; Kowalski K; Johnson AD; Patel R; Luo D; Chow-Maneval E; Hornby Z; Multani PS; Shaw AT; De Braud FG
Cancer Discov; 2017 Apr; 7(4):400-409. PubMed ID: 28183697
[TBL] [Abstract][Full Text] [Related]
37. An alternatively spliced form of the nerve growth factor receptor TrkA confers an enhanced response to neurotrophin 3.
Clary DO; Reichardt LF
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11133-7. PubMed ID: 7972023
[TBL] [Abstract][Full Text] [Related]
38. A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma.
Yamaguchi Y; Tabata K; Asami S; Miyake M; Suzuki T
Biol Pharm Bull; 2007 Apr; 30(4):638-43. PubMed ID: 17409494
[TBL] [Abstract][Full Text] [Related]
39. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).
Poulikakos PI; Persaud Y; Janakiraman M; Kong X; Ng C; Moriceau G; Shi H; Atefi M; Titz B; Gabay MT; Salton M; Dahlman KB; Tadi M; Wargo JA; Flaherty KT; Kelley MC; Misteli T; Chapman PB; Sosman JA; Graeber TG; Ribas A; Lo RS; Rosen N; Solit DB
Nature; 2011 Nov; 480(7377):387-90. PubMed ID: 22113612
[TBL] [Abstract][Full Text] [Related]
40. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
